PUNE, India, August 10, 2016 /PRNewswire/ --
This analysis indicates that the current medical aesthetic market is worth $52,405 million for both service and product revenue, which over the next five years will grow at 5.5% CAGR and is expected to hit $69,786 million in 2021. The invasive aesthetic procedures are set to grow at a CAGR of 4.3%, while non-invasive procedures will grow at a CAGR of 4.5% over the coming five years. Cosmetic surgery products generated $7,824.0 million in 2015 and have the potential to reach $13,934.0 million in 2021.
Complete report on Medical Aesthetics Market spreads across 335 pages, provides 180 tables & figures is now available at http://www.reportsnreports.com/reports/649547-global-medical-aesthetics-industry-injectables-energy-based-devices-cosmeceuticals-cosmetic-surgery-facial-aesthetics-implants-cosmetic-tourism-market-analysis-forecast-to-2021.html.
Nonsurgical treatments lead the way across the globe and are broadly classified into three major categories: injectable products, energy based devices and active cosmetics. Injectable products include neurotoxins such as Botox and dermal fillers such as Restylane and they have the largest market share. These are followed by energy-based devices such as lasers, radio frequency and intense pulsed light (IPL). Cosmeceuticals include skin care, eye care, skin lightening and scar care products.
The North American market accounts for about 45% of the global market. However, the dominance of the U.S. is shifting towards Asia, particularly in the energy- based devices segment. Asia is regarded as the next frontier and the number of physicians and clinics in China and India has been steadily rising, along with medical tourism in the region. In the injectables and devices category, the E.U. occupies the second position behind the U.S. Brazil continues to be a strong market for aesthetics and cosmetic procedures. The Russian market is also experiencing fast growth compared to many E.U. countries and the Russian market is particularly strong for devices and topicals.
Aesthetic practitioners have now the choice of new instrumentations such as soft and bendable needles, blunt-tip cannulas and injector pens for minimally invasive procedures. Recent years have seen wide acceptance by consumers for microneedle treatments administered via handheld guns, for restoring skin with vitamins, amino acids and hyaluronic acid. Consumer aesthetic products such as "micro- botox" and "bro-tox" are experiencing a steady growth. Adipose derived stem cells (ADSC) have gained acceptance for rejuvenating face and breasts, and stem cells from green apple, lilac and alpine roses are now being used as ingredients in topical cosmetics.
Order a Copy of Report at http://www.reportsnreports.com/purchase.aspx?name=649547.
Another growth market is for body shaping procedures that involves reduction of fat, cellulite, skin laxity and vein removal. An injectable drug ATX-101 (deoxycholic acid), currently in clinical trials is most likely to become a game changer in body contouring segment in the near future. On July 10, 2014, the FDA accepted the filing of New Drug Application (NDA) for this drug by Kythera Biopharmaceuticals. Plug-in at-home devices for treating sun damage, hair removal, skin discoloration, acne, hair growth, skin texture, microdermabrasion and cellulite continue to expand particularly in developed markets. As a new innovation, the aesthetic market is expected to witness the launch of transepidermal drug delivery technologies for facilitating topical treatments.
Companies Mentioned: Aerolase Corp., Adoderm GmbH, Aesthetic Dermal S.L., Allergan Inc., Allied Biomedical, Alma Lasers Ltd., Amiea Med, Andrew Technologies LLC, Anika Therapeutics Inc., Anteis S.A., Apira Science Inc., Aqtis Medical B.V., Baby Quasar, Benev Company, Biopelle Inc., Biotechnique Avance, Breit Aesthetics Ltd., BTL Industries Inc., Canfield Imaging Systems, Carol Cole Co., Chromogenex PLC, Classys Inc., Contura International A/S, CoolTouch Inc., Cutera Inc., Cynosure Inc., Deka Laser Technologies Inc., DermaMed Solutions LLC, Eclipse Aesthetic LLC, Edge Systems LLC, Ellipse A/S, Ellman International Inc., Endymed Medical Ltd., Energist Ltd., Envy Medical Inc., E-One-IPL, Episciences Inc., Erchonia Corp., EunSung Global Corp., Eurosilicone S.A.S., Focus Medical, Fotona D.D., Galderma S.A., General Project S.R.L., Hironic Co., Ltd., H&O Equipment N.V/S.A, Home Skinovations Ltd., Hongkong Spring International Industry Ltd. and more.
Explore other reports on Medical Devices Market http://www.reportsnreports.com/market-research/medical-devices/.
On similar lines, the Global Facial Aesthetics Market 2016-2020 research report forecasts a 9.82% CAGR for facial aesthetics during 2016 to 2020 led my companies like Allergan, Galderma SA, Ipsen Pharmaceuticals and Merz Pharma. To calculate the market size, the report considers the revenue generated from the sale of product types covering Botox (Botulinum toxin), Dermal fillers and Others (chemical peel and microdermabrasion). Read more at http://www.reportsnreports.com/reports/539136-global-facial-aesthetics-market-2016-2020.html .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
+ 1 888 391 5441
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts